Showing results (291-300 of 326) with videos related to
Sort By:
Pageof 33
Frontiers in Plant Science|August 21, 2024
Managing fruit rot diseases of Vaccinium corymbosumKerri A Neugebauer, Chakradhar Mattupalli, Mengjun Hu, et al.British Journal of Cancer|February 25, 2010
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experienceS Sutherland, S Ashley, D Miles, et al.Journal of Pharmacy Practice|December 28, 2017
Prevention Strategies Against HIV Transmission: A Proactive ApproachAntonio J Carrion, Jovan D Miles, Juan F Mosley, et al.Journal of the American Chemical Society|December 12, 2018
Total Enzyme Syntheses of Napyradiomycins A1 and B1Shaun M K McKinnie, Zachary D Miles, Peter A Jordan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancerJ A Oshaughnessy, J Blum, V Moiseyenko, et al.Cancer|December 20, 2002
Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trialLaura Biganzoli, Tanja Cufer, Peter Bruning, et al.Plos One|October 15, 2015
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic HistopathologyR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.Plant Disease|May 5, 2025
Development of a translation elongation factor 1-alpha (TEF) based TaqMan qPCR assay for Diaporthe humulicola, the causal agent of halo blight of hopRoss Joaquin Hatlen, Shay Szymanski, Nanci Adair, et al.Emerging Infectious Diseases|November 21, 1997
Quantitative microbiology: a basis for food safetyT A McMeekin, J Brown, K Krist, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysisA Brufsky, S B Kim, Ž Zvirbule, et al.Pageof 33